Bystolic Tablet
Product Images NDC 0456-1410

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Bystolic (NDC 0456-1410). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bystolic 01

Chemical structure of nebivolol hydrochloride, the active ingredient in Bystolic tablets, depicted as a detailed molecular diagram including fluorine atoms and hydrochloride.*

FDA Label Image

Bystolic 02

Chemical structure of nebivolol hydrochloride, showing the molecular arrangement including fluorinated aromatic rings and hydroxyl groups.*

FDA Label Image

Bystolic 03

Label for Bystolic (nebivolol hydrochloride) tablets, 2.5 mg strength. The oral tablet product is supplied in a package containing 30 tablets. The label indicates Rx only, includes the NDC number 0456-1402-30, and is distributed by Allergan, Inc.*

FDA Label Image

Bystolic 04

Packaging label for Bystolic (nebivolol) tablets, 2.5 mg strength, oral dosage form. The label shows a box for 100 tablets (10 blister cards of 10 tablets each) distributed by Allergan, Inc. The front panel features the product name, strength, and tablet description, with storage and handling instructions on the side panels, and includes a barcode and Allergan logo.*

FDA Label Image

Bystolic 05

Bystolic 5 mg tablet packaging label for nebivolol hydrochloride tablets, oral route, containing 30 tablets. The label is from Allergan, Inc. and includes dosage strength, quantity, and legal dispensing information.*

FDA Label Image

Bystolic 06

Label for Bystolic (nebivolol hydrochloride) tablets, 5 mg strength, oral dosage form. The label shows the product name, strength in a highlighted box, and quantity of 90 tablets. It includes directions for safe storage and child-resistant packaging. The labeler is Allergan, Inc., and the label notes licensing information and prescription-only status.*

FDA Label Image

Bystolic 07

Bystolic 5 mg tablets packaging label showing nebivolol hydrochloride as the active ingredient. The label indicates 100 tablets per container in 10 x 10 blister cards. The labeler is Allergan, Inc. The design features the Bystolic name and logo, strength in mg per tablet, and storage instructions.*

FDA Label Image

Bystolic 08

Label for Bystolic 10 mg tablets containing nebivolol hydrochloride. The package contains 30 oral tablets. The label highlights the strength as 10 mg per tablet. Distributed by Allergan, Inc., with storage instructions and child-resistant container information included in the text.*

FDA Label Image

Bystolic 09

Label for Bystolic 10 mg tablets (nebivolol hydrochloride) showing a count of 90 tablets. The label includes the product name, strength, dosage form, NDC number 0456-1410-90, and distributor Allergan, Inc. Usage and storage instructions are partially visible, including child-resistant container guidance and storage temperature.*

FDA Label Image

Bystolic 0a

Label for Bystolic (nebivolol hydrochloride) 20 mg tablets, an oral human prescription drug. The label indicates a package containing 30 tablets, manufactured by Allergan, Inc. The label includes NDC 0456-1420-30 and prescribing and storage instructions.*

FDA Label Image

Bystolic 0b

Label for Bystolic 20 mg tablets, containing nebivolol hydrochloride as the active ingredient. The oral tablet package includes 90 tablets. The label shows the Allergan, Inc. manufacturer and includes standard storage, safety, and distribution information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.